2bo9: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The only endogenous protein inhibitor known for metallocarboxypeptidases, (MCPs) is latexin, a 25-kDa protein discovered in the rat brain. Latexin, alias endogenous carboxypeptidase inhibitor, inhibits human CPA4 (hCPA4), whose expression is induced in prostate cancer cells after treatment with, histone deacetylase inhibitors. hCPA4 is a member of the A/B subfamily of, MCPs and displays the characteristic alpha/beta-hydrolase fold. Human, latexin consists of two topologically equivalent subdomains, reminiscent, of cystatins, consisting of an alpha-helix enveloped by a curved, beta-sheet. These subdomains are packed against each other through the, helices and linked by a connecting segment encompassing a third, alpha-helix. The enzyme is bound at the interface of these subdomains. The, complex occludes a large contact surface but makes rather few contacts, despite a nanomolar inhibition constant. This low specificity explains the, flexibility of latexin in inhibiting all vertebrate A/B MCPs tested, even, across species barriers. In contrast, modeling studies reveal why the N/E, subfamily of MCPs and invertebrate A/B MCPs are not inhibited. Major, differences in the loop segments shaping the border of the funnel-like, access to the protease active site impede complex formation with latexin., Several sequences ascribable to diverse tissues and organs have been, identified in vertebrate genomes as being highly similar to latexin. They, are proposed to constitute the latexin family of potential inhibitors., Because they are ubiquitous, latexins could represent for vertebrate A/B, MCPs the counterparts of tissue inhibitors of metalloproteases for matrix, metalloproteinases.
The only endogenous protein inhibitor known for metallocarboxypeptidases (MCPs) is latexin, a 25-kDa protein discovered in the rat brain. Latexin, alias endogenous carboxypeptidase inhibitor, inhibits human CPA4 (hCPA4), whose expression is induced in prostate cancer cells after treatment with histone deacetylase inhibitors. hCPA4 is a member of the A/B subfamily of MCPs and displays the characteristic alpha/beta-hydrolase fold. Human latexin consists of two topologically equivalent subdomains, reminiscent of cystatins, consisting of an alpha-helix enveloped by a curved beta-sheet. These subdomains are packed against each other through the helices and linked by a connecting segment encompassing a third alpha-helix. The enzyme is bound at the interface of these subdomains. The complex occludes a large contact surface but makes rather few contacts, despite a nanomolar inhibition constant. This low specificity explains the flexibility of latexin in inhibiting all vertebrate A/B MCPs tested, even across species barriers. In contrast, modeling studies reveal why the N/E subfamily of MCPs and invertebrate A/B MCPs are not inhibited. Major differences in the loop segments shaping the border of the funnel-like access to the protease active site impede complex formation with latexin. Several sequences ascribable to diverse tissues and organs have been identified in vertebrate genomes as being highly similar to latexin. They are proposed to constitute the latexin family of potential inhibitors. Because they are ubiquitous, latexins could represent for vertebrate A/B MCPs the counterparts of tissue inhibitors of metalloproteases for matrix metalloproteinases.


==About this Structure==
==About this Structure==
2BO9 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=VAL:'>VAL</scene>, <scene name='pdbligand=MPD:'>MPD</scene> and <scene name='pdbligand=ACN:'>ACN</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. This structure superseeds the now removed PDB entry 2BK7. Known structural/functional Site: <scene name='pdbsite=AC1:Acn+Binding+Site+For+Chain+L'>AC1</scene>. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BO9 OCA].  
2BO9 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=VAL:'>VAL</scene>, <scene name='pdbligand=MPD:'>MPD</scene> and <scene name='pdbligand=ACN:'>ACN</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. This structure supersedes the now removed PDB entry 2BK7. Known structural/functional Site: <scene name='pdbsite=AC1:Acn+Binding+Site+For+Chain+L'>AC1</scene>. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BO9 OCA].  


==Reference==
==Reference==
Line 13: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Aviles, F.X.]]
[[Category: Aviles, F X.]]
[[Category: Bonet, R.]]
[[Category: Bonet, R.]]
[[Category: Garcia-Castellanos, R.]]
[[Category: Garcia-Castellanos, R.]]
[[Category: Gomis-Rueth, F.X.]]
[[Category: Gomis-Rueth, F X.]]
[[Category: Pallares, I.]]
[[Category: Pallares, I.]]
[[Category: Vendrell, J.]]
[[Category: Vendrell, J.]]
Line 32: Line 32:
[[Category: x-ray crystal structure]]
[[Category: x-ray crystal structure]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:26:16 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:39:50 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA